Skip to main content
Atrás
Watch Compare

Black Diamond Therapeutics, Inc.

Calidad de datos: 83%
BDTX
Nasdaq Manufacturing Chemicals
$2.58
▲ $0.08 (3.00%)
Cap. Mercado: 147.52 M
Precio
$2.58
Cap. Mercado
147.52 M
Rango del Día
$2.40 — $2.58
Rango de 52 Semanas
$1.30 — $4.94
Volumen
638,017
Apertura $2.49
Promedio 50D / 200D
$2.31
11.65% above
Promedio 50D / 200D
$2.93
12.03% below

Quick Summary

Puntos Clave

ROE of 17.29% — decent returns on equity
Generating 29.61 M in free cash flow
P/E of 6.60 — trading at a low valuation
Cash machine — converts 132.40% of earnings into free cash flow

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
17.29%
Above sector avg (-53.41%)
ROIC6.78%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio8.94
Interest CoverageN/A

Valoración

PE (TTM)
6.60
Above sector avg (-1.48)
P/B Ratio1.17
EV/EBITDA9.32
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E 6.6 -1.5
P/B 1.2 1.6
ROE % 17.3 -53.4
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

ETFs Holding This Stock

AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) 22.37 M
ROE 17.29% ROA 13.80%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) 29.61 M
ROIC 6.78% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 8.94
Interest Coverage N/A Asset Turnover N/A
Working Capital 123.45 M Tangible Book Value 126.15 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 6.60 Forward P/E N/A
P/B Ratio 1.17 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 9.32 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 20.07%
Market Cap 147.52 M Enterprise Value 116.65 M
Per Share
EPS (Diluted TTM) 0.39 Revenue / Share N/A
FCF / Share 0.52 OCF / Share 0.52
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 132.40%
SBC-Adj. FCF 22.41 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income 22.37 M -69.68 M -82.44 M -91.17 M -125.60 M
EPS (Diluted) 0.39 -1.27 -1.88 -2.52 -3.47
Gross Profit — — — — —
Operating Income 12.52 M -78.78 M -86.46 M -92.83 M -126.87 M
EBITDA — — — — —
R&D Expenses 33.56 M 51.31 M 59.35 M 64.44 M 96.83 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — — 0.0
Income Tax 0.0 0.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 143.01 M 122.64 M 158.57 M 156.26 M 247.68 M
Total Liabilities 30.80 M 39.36 M 41.83 M 40.56 M 51.78 M
Shareholders' Equity 112.21 M 83.29 M 116.74 M 115.70 M 195.90 M
Total Debt — — — — —
Cash & Equivalents 20.99 M 36.44 M 56.22 M 34.32 M 65.80 M
Current Assets 132.44 M 101.18 M 134.03 M 127.71 M 215.70 M
Current Liabilities 15.73 M 20.57 M 19.65 M 15.26 M 23.64 M